TY - JOUR T1 - African-Ancestry Associated Gene Expression Signatures and Pathways in Triple Negative Breast Cancer, a Comparison across Women of African Descent JF - medRxiv DO - 10.1101/2022.01.27.22269747 SP - 2022.01.27.22269747 AU - Rachel Martini AU - Princesca Delpe AU - Timothy R. Chu AU - Kanika Arora AU - Brittany Lord AU - Akanksha Verma AU - Yalei Chen AU - Endale Gebregzabher AU - Joseph K. Oppong AU - Ernest K. Adjei AU - Aisha Jibril AU - Baffour Awuah AU - Mahteme Bekele AU - Engida Abebe AU - Ishmael Kyei AU - Frances S. Aitpillah AU - Michael O. Adinku AU - Kwasi Ankomah AU - Ernest B. Osei-Bonsu AU - Dhananjay Chitale AU - Jessica M. Bensenhaver AU - Saul David Nathanson AU - LaToya Jackson AU - Evelyn Jiagge AU - Lindsay F. Petersen AU - Erica Proctor AU - Kofi K. Gyan AU - Lee Gibbs AU - Zarko Monojlovic AU - Rick Kittles AU - Jason White AU - Clayton Yates AU - Upender Manne AU - Kevin Gardner AU - Nigel Mongan AU - Esther Cheng AU - Paula Ginter AU - Syed Hoda AU - Olivier Elemento AU - Nicolas Robine AU - Andrea Sboner AU - John Carpten AU - Lisa Newman AU - Melissa B. Davis Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/01/28/2022.01.27.22269747.abstract N2 - Women of sub-Saharan African ancestry have disproportionately higher incidence of aggressive, early-onset Triple Negative Breast Cancer (TNBC), and TNBC mortality across all race groups. Population-based comparative studies show racial differences in TNBC tumor biology, with higher prevalence of basal-like and Quadruple-Negative subtypes in African Americans (AA). However, most investigations relied on self-reported race (SRR) of primarily United States (US) populations. However, given that genetic admixture in AAs is extremely heterogenous, and race-correlated social determinants can translate into biological differences, the true association of African ancestry with TNBC biology and gene expression is currently unclear. To address this, we conducted RNAseq on an international cohort of AAs, west and east Africans with TNBC. Using genetic ancestry estimation in this African-enriched cohort, we identified 613 genes associated with African ancestry and more than 2200 genes associated with regional-level African ancestry. Functional enrichment and deconvolution revealed tumor-associated immune cell infiltration and activity.STATEMENT OF SIGNIFICANCE Using a rigorous ancestry quantification process, we show that TNBC has ancestry-associated gene expression profiles, linked to immunological landscapes, which may contribute to racial differences in clinical outcomes. This is the first study to show the definitive link to tumor immunological landscape, associated with African ancestry, using a multiethnic African-enriched cohort.Competing Interest StatementCY received consultant/honorarium from Amgen, QED Therapeutics, and Riptide Biosciences. CY is an owner of stocks in Riptide Biosciences.Funding StatementThis work was supported by funding from Susan G. Komen (awarded to LN), and from U54-MD007585-26 (NIH/NIMHD), U54 CA118623 (NIH/NCI), and Department of Defense Grant (PC170315P1, W81XWH-18-1-0589) awarded to CY. These studies were partly supported by 5U54CA118948 (NIH/NCI) and by institutional funds (Department of Pathology and School of Medicine of the University of Alabama at Birmingham, UAB) awarded to UM. We acknowledge the help provided by the UAB Tissue Biorepository Shared Facility grant of the UAB OCCC, P30CA013148.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Weill Cornell Medical College gave ethical approval for this work. IRB of Henry Ford Health System gave ethical approval for this work. IRB of University of Michigan gave ethical approval for this work. IRB of University of Alabama Birmingham gave ethical approval for this work. IRB of Komfo Anokye Teaching Hospital gave ethical approval for this work. IRB of Millennium Medical College St. Paul's Hospital gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data generated in this study are not publicly available due to the nondisclosure of genetic data issued through the Ministries of Health at corresponding African sites. These data must be approved for use by these entities, but may be available upon reasonable request from the corresponding author. ER -